Cargando…

Effect of half adult dose of oral Rifampicin (300mg) in patients with idiopathic central serous chorioretinopathy

OBJECTIVES: To evaluate the effect of half adult dose of oral Rifampicin on mean change in best corrected visual acuity and central macular thickness in patients with central serous chorioretinopathy. METHODS: Thirty-eight eyes of 31 patients with idiopathic central serous chorioretinopathy (CSCR) w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Muhammad Saim, Sameen, Murtaza, Lodhi, Arshad Ali, Ahmed, Munawar, Ahmed, Noman, Kamal, Mustafa, Junejo, Sameen Afzal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103125/ https://www.ncbi.nlm.nih.gov/pubmed/27882013 http://dx.doi.org/10.12669/pjms.325.10755

Ejemplares similares

Efficacy of Gatifloxacin in Acute Bacterial Corneal ulcer
por: Afzal Junejo, Sameen, et al.
Publicado: (2013)

Efficacy of oral rifampicin in chronic central serous chorioretinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2018)

Outcome of monocular surgery for horizontal strabismus in Hyderabad
por: Junejo, Sameen A, et al.
Publicado: (2010)

Choroidal vascularity changes in idiopathic central serous chorioretinopathy after half-fluence photodynamic therapy
por: Ma, Dae Joong, et al.
Publicado: (2018)

Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
por: Naseripour, Masood, et al.
Publicado: (2016)

Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series
por: Al-Hinai, Ahmed S., et al.
Publicado: (2011)

Effect of altering the regime of oral rifampicin therapy in the treatment of persistent central serous chorioretinopathy
por: Loya, Hina, et al.
Publicado: (2019)

Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy
por: Sandeep, K, et al.
Publicado: (2023)

Visual outcome of cataract surgery in a tertiary care teaching hospital
por: Junejo, Murtaza Sameen, et al.
Publicado: (2022)

Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
por: Ratanasukon, Mansing, et al.
Publicado: (2013)

Long-Term Effect of Half-Fluence Photodynamic Therapy on Fundus Autofluorescence in Acute Central Serous Chorioretinopathy
por: Stattin, Martin, et al.
Publicado: (2020)

Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy
por: Zakir, Shaik M, et al.
Publicado: (2009)

Role of topical beta blockers in regression of infantile capillary hemangioma
por: Junejo, Murtaza Sameen, et al.
Publicado: (2021)

Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
por: Fujita, Kyoko, et al.
Publicado: (2012)

Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
por: Sanguansak, Thuss, et al.
Publicado: (2015)

Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
por: Alovisi, Camilla, et al.
Publicado: (2020)

The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy
por: Rahbani-Nobar, Mohammad Bagher, et al.
Publicado: (2011)

The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients
por: Dang, Yalong, et al.
Publicado: (2013)

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
por: Atik, Alp, et al.
Publicado: (2017)

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
por: van Rijssen, Thomas J., et al.
Publicado: (2020)

Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking
por: Horiguchi, Etsuyo, et al.
Publicado: (2022)

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
por: Servillo, Andrea, et al.
Publicado: (2023)

The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes
por: Giannopoulos, Konstantinos, et al.
Publicado: (2021)

Traumatic central serous chorioretinopathy
por: Ramchandani, Suresh, et al.
Publicado: (2015)

Traumatic central serous chorioretinopathy
por: Steeples, Laura, et al.
Publicado: (2015)

Atypical Central Serous Chorioretinopathy
por: Cebeci, Zafer, et al.
Publicado: (2017)

Biomarkers for central serous chorioretinopathy
por: Nkrumah, Gideon, et al.
Publicado: (2020)

Central Serous Chorioretinopathy Classification
por: Vilela, Manuel, et al.
Publicado: (2020)

Brachytherapy for Central Serous Chorioretinopathy
por: Arora, Supriya, et al.
Publicado: (2022)

Central serous chorioretinopathy in pregnancy
por: Ochinciuc, Radu, et al.
Publicado: (2022)

Central serous chorioretinopathy: Treatment
por: Park, Jong Beom, et al.
Publicado: (2022)

Comparison of analgesic effect of preoperative topical Diclofenac versus Ketorolac on postoperative pain after Corneal Collagen Cross Linkage
por: Sameen, Murtaza, et al.
Publicado: (2017)

Efficacy of intravitreal bevacizumab combined with pan retinal photocoagulation versus panretinal photocoagulation alone in treatment of proliferative diabetic retinopathy
por: Sameen, Murtaza, et al.
Publicado: (2017)

Presumed Idiopathic Central Serous Chorioretinopathy in a 12-Year-Old Girl
por: Velazquez-Martin, Juan P., et al.
Publicado: (2012)

A rare case of idiopathic parafoveal telangiectasia associated with central serous chorioretinopathy
por: Thomas, Nicey Roy, et al.
Publicado: (2017)

Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report
por: Ng, Winnie WK, et al.
Publicado: (2011)

Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy
por: Kinoshita, Takamasa, et al.
Publicado: (2016)

Short-Term Choriocapillaris Changes in Patients with Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy
por: Nassisi, Marco, et al.
Publicado: (2017)

Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
por: Zeng, Miao, et al.
Publicado: (2022)

Half-fluence Photodynamic Therapy for Central Serous Chorioretinopathy in a Patient Receiving Corticosteroids for Behçet’s Uveitis
por: Özdemir, Hüseyin Baran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vrgbbjvp7of8u83ej51j7uilp0